Table 2.
Distribution of Streptococcus pneumoniae antimicrobial non-susceptibility among age groups
| Age groups in months | Non-susceptibility (ns) or resistance (r) to antibiotics, n (%) | MDR, n (%) | |||
|---|---|---|---|---|---|
| Penicillin (ns) | Erythromycin (ns) | Clindamycin (r) | TMP-SMX (ns) | ||
| 0–23a (n = 92) | 18 (19.6) | 21 (22.8) | 19 (20.7) | 25 (27.2) | 14 (15.2) |
| 24–47 (n = 199) | 27 (13.6) | 40 (20.1) | 31 (15.6) | 53 (26.6) | 23 (11.6) |
| P value | 0.186 | 0.593 | 0.283 | 0.923 | 0.382 |
| 48–71 (n = 76) | 13 (17.1) | 17 (22.4) | 12 (15.8) | 22 (28.9) | 9 (11.8) |
| P value | 0.683 | 0.944 | 0.422 | 0.799 | 0.529 |
| Total | 58 (15.8) | 78 (21.3) | 62 (16.9) | 100 (27.3) | 46 (12.5) |
TMP-SMX trimethoprim–sulphamethoxazole, MDR multidrug resistance
aReference group for each comparison (chi-squared test)